Looking for Multi-Biomarker Panel Signature in HER2-Negative Breast Cancer through TNM-Based Stages Using Systems Biology Techniques
Breast cancer as the second most common cause of death among women should be given an special attention for improving survival rates by considering early diagnosis and screening programmes. However, most of the patients with BC disease are diagnosed at late stages of the disease.
